| Literature DB >> 34426963 |
Hiroo Terashi1, Kenji Endo2, Haruhisa Kato1, Nobuhiro Ido1, Hitoshi Aizawa1.
Abstract
INTRODUCTION: The aim of this study was to characterize the associations between sagittal spinopelvic alignment and motor symptoms in patients with Parkinson's disease (PD).Entities:
Keywords: motor symptoms; parkinson disease; postural deformity; sagittal spinopelvic alignment
Mesh:
Year: 2021 PMID: 34426963 PMCID: PMC9290481 DOI: 10.1111/ane.13521
Source DB: PubMed Journal: Acta Neurol Scand ISSN: 0001-6314 Impact factor: 3.915
FIGURE 1Radiographic parameters of sagittal alignment. SVA, sagittal vertical axis
Clinical features and spinopelvic alignment in patients with Parkinson's disease
| Patients (n=79) | Males (n=39) | Females (n=40) |
| |
|---|---|---|---|---|
| Age (years) | 70.0 (66.0–73.5) | 71.2±4.6 | 68.4±6.0 | 0.021 |
| Height (m) | 1.59±0.08 | 164.6±6.3 | 154.4±5.5 | <0.001 |
| Body mass index | 22.0±3.2 | 22.6±3.2 | 21.4±3.0 | 0.088 |
| Disease duration (years) | 2.8 (1.1–6.5) | 3.5 (1.8–7.8) | 2.1 (0.7–5.6) | 0.048 |
| MMSE score | 28.0 (27.0–29.0) | 28.0 (27.0–29.0) | 29.0 (27.0–29.5) | 0.222 |
| Modified HY stage | 2.0 (2.0–3.0) | 2.0 (2.0–2.8) | 2.5 (2.0–3.0) | 0.362 |
| MDS‐UPDRS part III score | 16.0 (11.0–26.0) | 19.0 (13.0–26.0) | 15.0 (11.0–25.0) | 0.410 |
| Bradykinesia score | 10.0 (6.5–15.5) | 10.6±5.7 | 11.7±8.1 | 0.527 |
| Axial motor score | 3.0 (2.0–6.0) | 3.0 (2.0–5.5) | 4.0 (1.0–7.0) | 0.859 |
| LEDD (mg) | 300.0 (25.0–517.1) | 340.0 (100.0–563.2) | 150.0 (0.0–500.0) | 0.084 |
| DADD (mg) | 0.0 (0.0–141.7) | 0.0 (0.0–150.0) | 0.0 (0.0–67.4) | 0.524 |
| Spinopelvic alignment | ||||
| Cobb angle (°) | 10.0 (8.0–15.5) | 10.0 (7.5–11.5) | 12.0 (8.0–24.0) | 0.019 |
| SVA (mm) | 54.0 (27.5–95.5) | 59.0 (32.0–92.0) | 48.5 (19.5–96.0) | 0.573 |
| Cervical SVA (mm) | 29.0 (23.5–40.0) | 37.0 (27.0–50.0) | 26.0 (13.0–32.5) | <0.001 |
| Cervical | 12.0 (3.0–21.0) | 14.0 (6.0–20.0) | 12.0 (−3.0–24.5) | 0.356 |
| T1 slope (°) | 35.0 (29.0–43.5) | 37.0 (30.5–44.5) | 32.5 (26.0–42.0) | 0.115 |
| Thoracic | 33.0 (24.5–41.0) | 36.0 (29.0–41.5) | 29.0 (20.5–41.0) | 0.069 |
| Lumbar lordosis (°) | 40.0 (31.5–50.5) | 39.0 (31.0–50.0) | 41.5 (35.5–55.5) | 0.322 |
| Sacral slope (°) | 31.0 (25.0–39.0) | 29.0 (24.0–35.0) | 32.5 (26.0–40.0) | 0.220 |
|
| 18.0 (13.0–23.5) | 17.0 (11.0–21.0) | 20.5 (14.5–24.5) | 0.034 |
| Pelvic incidence (°) | 49.0 (42.0–57.0) | 46.0 (42.0–50.5) | 52.5 (42.0–62.0) | 0.028 |
Data are mean±SD or median with interquartile ranges.
Abbreviations: axial motor scores, the sum of the scores of the items of MDS‐UPDRS part III on “axial symptoms” items 3.1, 3.9, 3.10, 3.12, and 3.13.; bradykinesia scores, the sum of the scores of the items of MDS‐UPDRS part III on “bradykinesia” items 3.4–8, and 3.14; DADD, dopamine agonist daily dose; LEDD, levodopa equivalent daily dose; MDS‐UPDRS part III score, Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale part III score; MMSE, Mini‐Mental State Examination; modified HY stage, modified Hoehn and Yahr stage;SVA, sagittal vertical axis.
Student's t‐test,
Mann‐Whitney U test.
Relationship between spinopelvic alignment parameters in male patients with Parkinson disease
| SVA | cervical SVA | Cervical | T1 slope | Thoracic | Lumbar lordosis | Sacral slope |
| Pelvic incidence | |
|---|---|---|---|---|---|---|---|---|---|
| SVA | |||||||||
| Cervical SVA | 0.355 | ||||||||
| Cervical | −0.059 | −0.357 | |||||||
| T1 slope | 0.464 | 0.509 | 0.267 | ||||||
| Thoracic | 0.067 | 0.379 | −0.194 | 0.242 | |||||
| Lumbar lordosis | −0.521 | −0.249 | 0.192 | −0.326 | 0.238 | ||||
| Sacral slope | −0.267 | −0.225 | 0.295 | −0.166 | 0.079 | 0.868 | |||
|
| 0.339 | 0.190 | −0.132 | 0.182 | 0.017 | −0.239 | −0.276 | ||
| Pelvic incidence | −0.030 | −0.052 | 0.101 | −0.065 | 0.212 | 0.562 | 0.635 | 0.458 |
Data are Spearman's rank correlation coefficients (ρ).
Abbreviation: SVA, sagittal vertical axis.
p<0.05,
p<0.01.
Relationship between spinopelvic alignment parameters in female patients with Parkinson disease
| SVA | cervical SVA | Cervical | T1 slope | Thoracic | Lumbar lordosis | Sacral slope |
| Pelvic incidence | |
|---|---|---|---|---|---|---|---|---|---|
| SVA | |||||||||
| Cervical SVA | 0.343 | ||||||||
| Cervical | 0.210 | −0.230 | |||||||
| T1 slope | 0.586 | 0.354 | 0.612 | ||||||
| Thoracic | 0.130 | 0.173 | 0.545 | 0.497 | |||||
| Lumbar lordosis | −0.429 | −0.237 | 0.227 | −0.065 | 0.341 | ||||
| Sacral slope | −0.033 | −0.129 | 0.279 | 0.052 | 0.249 | 0.788 | |||
|
| 0.418 | 0.351 | −0.067 | 0.216 | 0.078 | −0.179 | 0.036 | ||
| Pelvic incidence | 0.240 | 0.092 | 0.184 | 0.174 | 0.230 | 0.492 | 0.774 | 0.608 |
Data are Spearman's rank correlation coefficients (ρ).
Abbreviation: SVA, sagittal vertical axis.
p<0.05,
p<0.01.
Associations between spinopelvic alignment and clinical parameters in male patients with Parkinson's disease
| Modified HY stage | MDS‐UPDRS part III score | Bradykinesia score | Axial motor score | |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| SVA | 0.231 | 0.190 | 0.232 | 0.183 | 0.386 | 0.035 | 0.412 | 0.018 |
| Cervical SVA | 0.144 | 0.418 | 0.429 | 0.011 | 0.576 | 0.001 | 0.353 | 0.045 |
| Cervical | 0.239 | 0.178 | 0.084 | 0.635 | 0.050 | 0.794 | 0.151 | 0.405 |
| T1 slope | 0.313 | 0.070 | 0.274 | 0.112 | 0.419 | 0.020 | 0.358 | 0.040 |
| Thoracic | 0.077 | 0.640 | <0.001 | 0.999 | 0.165 | 0.338 | 0.160 | 0.331 |
| Lumbar lordosis | −0.004 | 0.983 | −0.107 | 0.533 | −0.184 | 0.314 | −0.106 | 0.547 |
| Sacral slope | 0.031 | 0.862 | −0.067 | 0.704 | −0.129 | 0.492 | −0.042 | 0.814 |
|
| −0.066 | 0.714 | −0.040 | 0.824 | 0.061 | 0.747 | −0.056 | 0.757 |
| Pelvic incidence | −0.015 | 0.933 | −0.093 | 0.595 | −0.084 | 0.651 | −0.080 | 0.654 |
Data are standardized regression coefficients (β weights).
Abbreviations: axial motor score, the sum of the scores of the items of MDS‐UPDRS part III on “axial symptoms” items 3.1, 3.9, 3.10, 3.12, and 3.13.; bradykinesia score, the sum of the scores of the items of MDS‐UPDRS part III on “bradykinesia” items 3.4–8, and 3.14; MDS‐UPDRS part III score, Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale part III score; modified HY stage, modified Hoehn and Yahr stage; SVA, sagittal vertical axis.
Associations between spinopelvic alignment and clinical parameters in female patients with Parkinson's disease
| Modified HY stage | MDS‐UPDRS part III score | Bradykinesia score | Axial motor score | |||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| SVA | 0.284 | 0.080 | 0.293 | 0.110 | 0.344 | 0.051 | 0.399 | 0.013 |
| Cervical SVA | 0.506 | 0.002 | 0.316 | 0.093 | 0.429 | 0.016 | 0.489 | 0.003 |
| Cervical | −0.183 | 0.258 | −0.005 | 0.978 | −0.067 | 0.705 | −0.182 | 0.265 |
| T1 slope | 0.366 | 0.021 | 0.243 | 0.185 | 0.331 | 0.058 | 0.344 | 0.032 |
| Thoracic | 0.265 | 0.118 | 0.442 | 0.018 | 0.385 | 0.035 | 0.250 | 0.145 |
| Lumbar lordosis | −0.327 | 0.059 | −0.047 | 0.814 | −0.231 | 0.228 | −0.342 | 0.050 |
| Sacral slope | −0.482 | 0.004 | −0.122 | 0.540 | −0.304 | 0.110 | −0.418 | 0.015 |
|
| 0.304 | 0.065 | 0.126 | 0.507 | 0.151 | 0.411 | 0.361 | 0.029 |
| Pelvic incidence | −0.165 | 0.326 | −0.007 | 0.971 | −0.133 | 0.469 | −0.074 | 0.665 |
Data are standardized regression coefficients (β weights).
Abbreviations: axial motor score, the sum of the scores of the items of MDS‐UPDRS part III on “axial symptoms” items 3.1, 3.9, 3.10, 3.12, and 3.13.; bradykinesia score, the sum of the scores of the items of MDS‐UPDRS part III on “bradykinesia” items 3.4–8, and 3.14; MDS‐UPDRS part III score, Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale part III score; modified HY stage, modified Hoehn and Yahr stage; SVA, sagittal vertical axis.
| Male patients | Female patients | |||||
|---|---|---|---|---|---|---|
| PIGD phenotype (n=23) | TD phenotype (n=16) |
| PIGD phenotype (n=26) | TD phenotype (n=11) |
| |
| Age (years) | 71.0±4.4 | 71.5±4.9 | 0.764 | 69.2±6.3 | 66.2±5.4 | 0.180 |
| Disease duration (years) | 5.5 (2.0–10.7) | 2.5 (1.6–3.7) | 0.030 | 4.3±4.9 | 2.5±3.3 | 0.268 |
| SVA (mm) | 73.4±46.5 | 45.1±28.8 | 0.037 | 68.2±63.3 | 41.6±49.8 | 0.222 |
| Cervical SVA (mm) | 39.7±17.6 | 37.2±15.3 | 0.648 | 28.5 (20.0–35.0) | 17.0 (7.0–28.0) | 0.051 |
| Cervical | 14.0 (9.0–17.5) | 11.0 (1.5–21.5) | 0.343 | 6.8±24.9 | 8.8±17.1 | 0.805 |
| T1 slope (°) | 39.9±9.3 | 34.6±10.9 | 0.110 | 36.2±11.4 | 28.6±13.6 | 0.092 |
| Thoracic | 36.1±10.1 | 35.1±12.4 | 0.769 | 31.4±12.0 | 27.8±12.0 | 0.415 |
| Lumbar lordosis (°) | 39.7±12.3 | 43.1±19.6 | 0.509 | 39.4±16.6 | 51.3±9.4 | 0.034 |
| Sacral slope (°) | 29.0 (25.5–34.0) | 31.0 (21.5–37.0) | 0.855 | 30.8±13.7 | 40.6±5.8 | 0.030 |
|
| 17.1±6.9 | 15.6±8.2 | 0.551 | 22.5 (14.0–27.0) | 20.0 (15.5–21.0) | 0.270 |
| Pelvic incidence (°) | 47.0 (45.0–50.5) | 44.0 (37.5–52.5) | 0.343 | 53.9±15.7 | 61.2±16.1 | 0.206 |
Data are mean±SD or median values and interquartile ranges.
Abbreviation: SVA, sagittal vertical axis.
Student's t‐test,
Mann‐Whitney U test.